PubMed

Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study.

Herder C, Peltonen M, Koenig W, Kräft I, Müller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson JG, Hämäläinen H, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindström J, Kolb H, Tuomilehto J.

Diabetes. 2006 Aug;55(8):2340-6.PMID: 16873699 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial.

Lindström J, Eriksson JG, Valle TT, Aunola S, Cepaitis Z, Hakumäki M, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Martikkala V, Moltchanov V, Rastas M, Salminen V, Sundvall J, Uusitupa M, Tuomilehto J.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S108-13.PMID: 12819313 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

Kosaka K, Noda M, Kuzuya T.

Diabetes Res Clin Pract. 2005 Feb;67(2):152-62.PMID: 15649575 [PubMed - indexed for MEDLINE]Related articles

Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).

Herder C, Kolb H, Koenig W, Haastert B, Müller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE.

Diabetes Care. 2006 Feb;29(2):368-71.PMID: 16443889 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.

Hämäläinen H, Rönnemaa T, Virtanen A, Lindström J, Eriksson JG, Valle TT, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Rastas M, Aunola S, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group.

Diabetologia. 2005 Nov;48(11):2248-53. Epub 2005 Oct 5.PMID: 16205886 [PubMed - indexed for MEDLINE]Related articles

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group.

N Engl J Med. 2001 May 3;344(18):1343-50.PMID: 11333990 [PubMed - indexed for MEDLINE]Related articlesFree article

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group.

Lancet. 2006 Nov 11;368(9548):1673-9.PMID: 17098085 [PubMed - indexed for MEDLINE]Related articles

The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.

Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group.

Diabetes Care. 2003 Dec;26(12):3230-6.PMID: 14633807 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study.

Herder C, Peltonen M, Koenig W, Sütfels K, Lindström J, Martin S, Ilanne-Parikka P, Eriksson JG, Aunola S, Keinänen-Kiukaanniemi S, Valle TT, Uusitupa M, Kolb H, Tuomilehto J; Finnish Diabetes Prevention Study Group.

Diabetologia. 2009 Mar;52(3):433-42. Epub 2009 Jan 8.PMID: 19130041 [PubMed - indexed for MEDLINE]Related articles

Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme.

Eriksson J, Lindström J, Valle T, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Lauhkonen M, Lehto P, Lehtonen A, Louheranta A, Mannelin M, Martikkala V, Rastas M, Sundvall J, Turpeinen A, Viljanen T, Uusitupa M, Tuomilehto J.

Diabetologia. 1999 Jul;42(7):793-801.PMID: 10440120 [PubMed - indexed for MEDLINE]Related articles

Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study.

Laaksonen DE, Lindström J, Lakka TA, Eriksson JG, Niskanen L, Wikström K, Aunola S, Keinänen-Kiukaanniemi S, Laakso M, Valle TT, Ilanne-Parikka P, Louheranta A, Hämäläinen H, Rastas M, Salminen V, Cepaitis Z, Hakumäki M, Kaikkonen H, Härkönen P, Sundvall J, Tuomilehto J, Uusitupa M; Finnish diabetes prevention study.

Diabetes. 2005 Jan;54(1):158-65.PMID: 15616024 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.

Siitonen N, Lindström J, Eriksson J, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Tuomilehto J, Laakso M, Uusitupa M.

Diabetologia. 2004 Aug;47(8):1416-24. Epub 2004 Jul 28.PMID: 15309292 [PubMed - indexed for MEDLINE]Related articles

Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study.

Lindström J, Peltonen M, Eriksson JG, Aunola S, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study (DPS) Group.

Diabetes Care. 2008 May;31(5):857-62. Epub 2008 Feb 5.PMID: 18252900 [PubMed - indexed for MEDLINE]Related articlesFree article

The Finnish Diabetes Prevention Study.

Uusitupa M, Louheranta A, Lindström J, Valle T, Sundvall J, Eriksson J, Tuomilehto J.

Br J Nutr. 2000 Mar;83 Suppl 1:S137-42.PMID: 10889804 [PubMed - indexed for MEDLINE]Related articles

Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).

Herder C, Haastert B, Müller-Scholze S, Koenig W, Thorand B, Holle R, Wichmann HE, Scherbaum WA, Martin S, Kolb H.

Diabetes. 2005 Dec;54 Suppl 2:S11-7.PMID: 16306328 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.PMID: 17680902 [PubMed - indexed for MEDLINE]Related articles

Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus.

Kim SH, Lee SJ, Kang ES, Kang S, Hur KY, Lee HJ, Ahn CW, Cha BS, Yoo JS, Lee HC.

Metabolism. 2006 Aug;55(8):1053-9.PMID: 16839841 [PubMed - indexed for MEDLINE]Related articles

Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation.

Hu G, Lindström J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J.

Arch Intern Med. 2004 Apr 26;164(8):892-6.PMID: 15111376 [PubMed - indexed for MEDLINE]Related articlesFree article

Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study.

Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, de Bruin TW, Blaak EE.

Diabetologia. 2006 Oct;49(10):2392-401. Epub 2006 Aug 3.PMID: 16896932 [PubMed - indexed for MEDLINE]Related articles

Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year.

Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE.

Int J Obes Relat Metab Disord. 2003 Mar;27(3):377-84.PMID: 12629566 [PubMed - indexed for MEDLINE]Related articles